IGF-1 is also secreted from prostate cancer cells in an autocrine manner and enhances prostate cancer growth via the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) signaling pathways (94). The gene discussed is WNK2; the disease is prostate carcinoma.